Topic:

April 2024

NATIONAL ADVISORY COMMITTEE OF IMMUNIZATION (NACI) RAPID RESPONSE: ADDITIONAL DOSE OF COVID-19 VACCINE IN IMMUNOCOMPROMISED INDIVIDUALS FOLLOWING 1- OR 2- DOSE PRIMARY SERIES

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Biogen Lupus Research | New Treatments in Development

Read

Anifrolumab Now Covered Under BC PharmaCare for Lupus Treatment

Read

Belimumab for Lupus Nephritis in BC Now Approved Under BC Renal Formulary

Read